ERC1 anticorps (N-Term)

N° du produit ABIN6256850

Cet anticorps Lapin Polyclonal détecte spécifiquement ERC1 dans WB et ELISA. Il présente une réactivité envers Humain, Souris et Rat.

Aperçu rapide pour ERC1 anticorps (N-Term) (ABIN6256850)

Antigène: ERC1 (ELKS/RAB6-Interacting/CAST Family Member 1 (ERC1))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ERC1 est non-conjugé

Application: Western Blotting (WB), ELISA

Détail du produit anti-ERC1 anticorps

Épitope: N-Term

Specificité: RB6I2 Antibody detects endogenous levels of total RB6I2.

Homologie: Pig,Bovine,Horse,Sheep,Rabbit,Dog,Chicken

Purification: The antiserum was purified by peptide affinity chromatography using SulfoLink^TM Coupling Resin (Thermo Fisher Scientific).

Immunogène: A synthesized peptide derived from human RB6I2, corresponding to a region within N-terminal amino acids.

Isotype: IgG

Information d'application

Indications d'application: WB 1:500-1:2000, ELISA(peptide) 1:20000-1:40000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Date de péremption: 12 months

Détails sur ERC1

Antigène: ERC1 (ELKS/RAB6-Interacting/CAST Family Member 1 (ERC1))

Autre désignation: ERC1

Sujet:

Description: Regulatory subunit of the IKK complex. Probably recruits IkappaBalpha/NFKBIA to the complex. May be involved in the organization of the cytomatrix at the nerve terminals active zone (CAZ) which regulates neurotransmitter release. May be involved in vesicle trafficking at the CAZ. May be involved in Rab-6 regulated endosomes to Golgi transport.

Gene: ERC1

ID gène: 23085

UniProt: Q8IUD2

Pathways: SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2